OpenAlex
PricingAboutJobs
Log inGet started
Work

Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade

HTML

Year: 2006
Type: article
Source: Neuropharmacology
DOI: 10.1016/j.neuropharm.2006.04.007
Authors: Yuki Takada-Takatori, Toshiaki Kume, Mitsuhiro Sugimoto, Hiroshi Katsuki, Hachiro Sugimoto, Akinori Akaike
Institution: Kyoto University
Language: English

Topic: Nicotinic Acetylcholine Receptors Study
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: acetylcholinesterase inhibitors, Alzheimer's disease, glutamate excitotoxicity, nicotinic acetylcholine receptors, alpha4 nAChR, alpha7 nAChR, phosphatidylinositol 3-kinase, PI3K/Akt signaling, neuroprotection, apoptosis, donepezil, galantamine, tacrine, mecamylamine, Bcl-2, Fyn, JAK2, LY294002
SDG: Good health and well-being

Open Access status: closed

Funder: Smoking Research Foundation
OpenAlex ID: W1967347247
FWCI: 4.201
Cites: 42
Cited by: 200
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms